The indirect alloimmune response causes microvascular endothelial dysfunction-a possible role for alloantibody

Transplantation

Volumn 90, Issue 11, 2010, Pages 1157-1164

  Xu, Ying ^a   Chester, Adrian H ^a   Hariri, Batool ^b   McCormack, Ann ^a   Sarathchandra, Padmini ^a   Rose, Marlene L ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Alloantibody; Cardiac allograft vasculopathy; Endothelial dysfunction

Indexed keywords

ACETYLCHOLINE; ALLOANTIBODY; CD11B ANTIGEN; COMPLEMENT COMPONENT C4D; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NITROPRUSSIDE SODIUM;

ALLOIMMUNITY; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CORONARY ARTERY BLOOD FLOW; ENDOTHELIAL DYSFUNCTION; GRAFT RECIPIENT; IMMUNE RESPONSE; INFLAMMATORY INFILTRATE; ISOLATED HEART; LYMPHOCYTE DEPLETION; MICROVASCULARIZATION; MONOCYTE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; THYMECTOMY; VASCULAR RING;

ANIMALS; ANTIGENS, CD11B; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENT C4B; CORONARY CIRCULATION; CORONARY OCCLUSION; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; INFLAMMATION MEDIATORS; ISOANTIBODIES; MICROCIRCULATION; MONOCYTES; PEPTIDE FRAGMENTS; PERFUSION; RATS; THYMECTOMY; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC; VASODILATION; VASODILATOR AGENTS;

EID: 78650310613     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181fa9480     Document Type: Article

References (33)

1. Hollenberg SM, Klein LW, Parrillo JE, et al. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation 2001; 104: 3091.
2. Hollenberg SM, Klein LW, Parrillo JE, et al. Changes in coronary endothelial function predict progression of allograft vasculopathy after heart transplantation. J Heart Lung Transplant 2004; 23: 265.
3. Wildhirt SM, Weis M, SchulzeC, et al. Coronary flow reserve and nitric oxide synthases after cardiac transplantation in humans. Eur J Cardio-thorac Surg 2001; 19: 840.
4. Kübrich M, Petrakopoulou P, Kofler S, et al. Impact of coronary endothelial dysfunction on adverse long-term outcome after heart transplantation. Transplantation 2008; 85: 1580.
5. Perrault LP, Bidouard JP, Janiak P, et al. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation. J Heart Lung Transplant 1997; 16: 643.
6. Andriambeloson E, Bigaud M, Schraa EO, et al. Endothelial dysfunction and denudation in rat aortic allografts. Arterioscler Thromb Vasc Biol2001; 21: 67.
7. Andriambeloson E, Pally C, Hengerer B, et al. Transplantation-induced endothelial dysfunction as studied in rat aorta allografts. Transplantation 2001; 72: 1881.
8. Rogers NJ, Lechler RI. Allorecognition. Am J Transplant 2001; 1: 97.
9. Baker RJ, Hernandez-Fuentes MP, Brookes PA, et al. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: Implications for the pathogenesis of chronic allograft nephropathy. J Im-munol2001; 167: 7199.
10. Hornick PI, Mason PD, Baker RJ, et al. Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation 2000; 101: 2405.
11. Stanford RE, Ahmed S, Hodson M, et al. A role for indirect allorecognition in lung transplant recipients with obliterative bronchiolitis. Am J Transplant 2003; 3: 736.
12. Brennan TV, Jaigirdar A, Hoang V, et al. Preferential priming of alloreactive T cells with indirect reactivity. Am J Transplant 2009; 9: 709.
13. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. JHeart Lung Transplant 2005; 24: 1710.
14. Reed EF, Demetris AJ, Hammond E, et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006; 25: 153.
15. Hillebrands JL, Klatter FA, van den Hurk BM, et al. Origin of neointi-mal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001; 107: 1411.
16. Hornick P, Lechler R. Direct and indirect pathways of alloantigen recognition: Relevance to acute and chronic allograft rejection. Nephrol Dial Transplant 1997; 12: 1806.
17. Vella JP, Spadafora-Ferreira M, Murphy B, et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997; 64: 795.
18. Shirwan H, Mhoyan A, Yolcu ES, et al. Chronic cardiac allograft rejection in a rat model disparate for one single class IMHC molecule is associated with indirect recognition by CD4(+) Tcells. Transpl Immunol 2003; 11:179.
19. Easterfield AJ, Delriviere L, Wallduck MS, et al. Alloantibody-associated chronic rejection of MHC class I-disparate heart grafts is modulated by intravenous soluble donor alloantigen. Transpl Im-munol2007; 18: 138.
20. Minami K, Murata K, Lee CY, et al. C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats. Am J Transplant 2006; 6: 923.
21. Rose ML. De novo production of antibodies after heart or lung transplantation should be regarded as an early warning system. J Heart Lung Transplant 2004; 23: 385.
22. Uehara S, Chase CM, Cornell LD, et al. Chronic cardiac transplant arteriopathy in mice: Relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant 2007; 7: 57.
23. + T cell depletion does not alter development of chronic vascular rejection in a rat heart allograft model. Transplantation 1994; 57: 1238.
24. + T lymphocytes prevents the development of cardiac allograft vasculopathy. Transplantation 2002; 73: 1116.
25. Mankad PS, Amrani M, Rothery S, et al. Relative susceptibility of en-dothelium and myocardial cells to ischaemia-reperfusion injury. Acta Physiol Scand 1997; 161: 103.
26. Nyborg NC. Ageing is associated with increased 5-HT2-receptor affinity and decreased receptor reserve in rat isolated coronary arteries. Br J Pharmacol 1991; 102: 282.
27. Rienstra H, Boersema M, Onuta G, et al. Donor and recipient origin of mesenchymal and endothelial cells in chronic renal allograft remodeling. Am J Transplant 2009; 9: 463.
28. Gill JS, Landsberg D, Johnston O, et al. Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection. Transplantation 2010; 89: 178.
29. Jindra PT, Hsueh A, Hong L, et al. Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol 2008; 180: 2214.
30. Ito A, Tsao PS, Adimoolam S, et al. Novel mechanism for endothelial dysfunction: Dysregulationofdimethylarginine dimethylaminohydro-lase. Circulation 1999; 99: 3092.
31. Weis M, Cooke JP. Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway. Arterioscler Thromb Vasc Biol 2003; 23: 567.
32. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
33. Mankad PS, Chester AH, Yacoub MH. 5-Hydroxytryptamine mediates endothelium dependent coronary vasodilatation in the isolated rat heart by the release of nitric oxide. Cardiovasc Res 1991; 25: 244.